Literature DB >> 24559565

The dermatologist and the HIV/AIDS pandemic.

Erwin Tschachler1.   

Abstract

The clinical course of HIV disease has changed dramatically over the last 30 years due to insights into the disease pathogenesis, provided by basic biomedical research, and due to the boost of antiretroviral drugs that are able to break the vicious circle of viral propagation and damage to the immune system. Dermatologists were pivotal in the identification of the then new disease in the early 1980s, and continue to play an important role in identifying sentinel skin and mucous membrane conditions associated with HIV-1 disease, diagnosing and treating side effects of antiretroviral drug therapies, and helping to curb the spread of HIV by control of other sexually transmitted infections.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24559565     DOI: 10.1016/j.clindermatol.2013.08.012

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  3 in total

Review 1.  Preexposure Prophylaxis for Human Immunodeficiency Virus Infection for Men Who Have Sex with Men and Transgender Persons:: What Dermatologists Need to Know.

Authors:  Kenneth A Katz; Andrew J Park; Julia L Marcus
Journal:  Dermatol Clin       Date:  2019-11-23       Impact factor: 3.478

Review 2.  Climate change, human migration, and skin disease: is there a link?

Authors:  Johannes F Dayrit; Audi Sugiharto; Sarah J Coates; Don Eliseo Lucero-Prisno; Mark Denis D Davis; Louise K Andersen
Journal:  Int J Dermatol       Date:  2021-05-10       Impact factor: 3.204

3.  Mucocutaneous manifestations and their relationship with CD4 T-lymphocyte count in hospitalized patients infected with the human immunodeficiency virus (HIV) in Medellín, Colombia

Authors:  Ana María Sanín; Ángela María Londoño; Verónica Gil; Ana María Mejía; Hernán Darío Aguirre; Elsa María Vásquez; Catalina Valencia; Carolina Cardona
Journal:  Biomedica       Date:  2022-06-01       Impact factor: 1.173

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.